Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various...
Company Valuation
Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers.
Target Price
The average target price of MBOT is 7.1 and suggests 165% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa
Buy
Sell